[Gene expression profile of spinal ventral horn in ALS]

[Gene expression profile of spinal ventral horn in ALS] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Gene expression profile of spinal ventral horn in ALS] Abstract Text:

Masahiko Yamamoto,Fumiaki Tanaka,Gen Sobue,Masahiko Yamamoto,Fumiaki Tanaka,Gen Sobue,

The causative pathomechanism of sporadic amyotrophic lateral sclerosis (ALS) is not clearly understood. Using microarray technology combined with laser-captured microdissection, gene expression profiles of degenerating spinal motor neurons as well as spinal ventral horn from autopsied patients with sporadic ALS were examined. Spinal motor neurons showed a distinct gene expression profile from the whole spinal ventral horn. Three percent of genes examined were significantly downregulated, and 1% were upregulated in motor neurons. In contrast with motor neurons, the total spinal ventral horn homogenates demonstrated 0.7% and 0.2% significant upregulation and downregulation of gene expression, respectively. Downregulated genes in motor neurons included those associated with cytoskeleton/axonal transport, transcription and cell surface antigens/receptors, such as dynactin 1 (DCTN1) and early growth response 3 (EGR3). In particular, DCTN1 was markedly downregulated in most residual motor neurons prior to the accumulation of pNF-H and ubiquitylated protein. Promoters for cell death pathway, death receptor 5 (DR5), cyclins C (CCNC) and A1 (CCNA), and caspases were upregulated, whereas cell death inhibitors, acetyl-CoA transporter (ACATN) and NF-kappaB (NFKB) were also upregulated. In terms of spinal ventral horn, the expression of genes related to cell surface antigens/receptors, transcription and cell adhesion/ECM were increased. The gene expression resulting in neurodegenerative and neuroprotective changes were both present in spinal motor neurons and ventral horn. Moreover, Inflammation-related genes, such as belonging to the cytokine family were not, however, significantly upregulated in either motor neurons or ventral horn. The sequence of motor neuron-specific gene expression changes from early DCTN1 downregulation to late CCNC upregulation in sporadic ALS can provide direct information on the genes leading to neurodegeneration and neuronal death, and are helpful for developing new therapeutic strategies.

[Gene expression profile of spinal ventral horn in ALS] Publishing Authors By Initials

M Yamamoto,F Tanaka,G Sobue,M Yamamoto,F Tanaka,G Sobue,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Gene expression profile of spinal ventral horn in ALS] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Brain and nerve = Shinkei kenkyū no shinpo

VOLUME: 59

Page Numbers: 1129-39

Journal Abbreviation:

ISSN: 1881-6096

DAY: 30

MONTH: Oct

YEAR: 2007

[Gene expression profile of spinal ventral horn in ALS] Information

Number of References:

LANGUAGE: jpn

NlmUniqueID: 101299709

[Gene expression profile of spinal ventral horn in ALS] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Gene expression profile of spinal ventral horn in ALS] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Gene expression profile of spinal ventral horn in ALS]

AFFILIATION: Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Brain Nerve

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Gene expression profile of spinal ventral horn in ALS Related Publications

• A message from the New Editor-in-Chief.
• A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity.
• CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
• Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries.
• Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome.
• Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
• Contrast-enhanced 2D cine phase MR angiography for measurement of basilar artery blood flow in posterior circulation ischemia.
• Correlation between multiple phosphorylation of gizzard myosin light chains and actin-activated myosin ATPase activity.
• Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signaling.
• Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson's disease.
• Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.
• Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
• Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis.
• Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity.
• Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling.
• Isolation and characterization of a calmodulin binding fragment of chicken gizzard caldesmon.
• Multiple cerebellar infarcts: clinical and pathophysiologic features.
• Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A.
• Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders.
• Pupillary supersensitivity and visual disturbance in Parkinson's disease.
• Pyramidal tract degeneration in sporadic Creutzfeldt-Jakob disease.
• Quantitative determinations of calmodulin in the supernatant and particulate fractions of mammalian tissues.
• Small neurons may be preferentially affected in ganglionopathy.
• The Japan cancer surveillance report: incidence of childhood, bone, penis and testis cancers.
• The video images of sleep attacks in Parkinson's disease.
• Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy.
• [Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy]
• [Envisioning quality measurement systems of cancer care]
• [Gene expression profile of spinal ventral horn in ALS]
• [Neurodegenerative diseases and Dorfin]